We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Public Health Advisory for Trasylol
FDA Issues Public Health Advisory for Trasylol
February 10, 2006
The FDA is warning doctors about risks associated with Bayer Pharmaceutical’s blood-loss treatment Trasylol, which has been linked in published studies to increased rates of kidney failure, heart attack and stroke.